Robert Naviaux

Robert Naviaux (MD, PhD) is a researcher specialising in mitochondrial mechanisms of disease and development. He joined the Open Medicine Foundation's research team in 2016.

According to his OMF bio:


 * "Dr. Naviaux runs the Robert Naviaux Laboratory at UC San Diego [the University of California, San Diego, aka, UCSD], which is doing genetic research into mitochondrial dysfunctions. He is founder and co-director of the Mitochondrial and Metabolic Disease Center at UCSD. Additionally, he is the co-founder and a former president of the Mitochondrial Medicine Society, and a founding  associate editor of the journal Mitochondrion. He studied biochemistry at Georg-August University in Göttingen, Germany.


 * Dr. Naviaux discovered the cause and created the diagnostic test for Alpers syndrome, a mitochondrial disease. He also works in oceanographic ecosystems research and is the director of the first FDA-approved clinical trial to study suramin as a treatment for autism."

Notable studies

 * Metabolic features of the cell danger response (2014)
 * Mitochondrial control of epigenetics (2008)
 * Developing a systematic approach to the diagnosis and classification of mitochondrial disease (2004)

ME/CFS Research

 * In March 2016, it was announced that the ME/CFS Severely Ill, Big Data Study had a significant result in the area of mitochondria. This resulted in the addition of Robert Naviaux to the research team


 * 2016, "Mitochondria Man Gets Money UK Goes Mega Chronic Fatigue Syndrome Research Moves Forward"

Talks & interviews
Mitochondria and Autism (2011)

Online presence

 * PubMed
 * Twitter
 * Facebook
 * Website
 * YouTube

Learn more

 * UCSD School of Medicine, Division of Genetics Faculty, Robert Naviaux
 * Naviaux Laboratory at UC San Diego